Monopril

Quick links to important sections

Monopril

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Monopril

What is Monopril?

Monopril is a medication belonging to the class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. It is primarily used in the management of cardiovascular conditions, specifically hypertension (high blood pressure) and heart failure.

Mechanism of Action

The active ingredient in Monopril is fosinopril. It works by interfering with the body's production of angiotensin II, a potent chemical that causes blood vessels to tighten and narrow. By inhibiting the enzyme responsible for creating this chemical, fosinopril allows blood vessels to relax and widen. This process helps to lower blood pressure and reduces the workload on the heart, making it easier for the heart to pump blood throughout the body.

Therapeutic Use

As a cardiovascular treatment, Monopril is utilized for its long-acting properties, typically providing blood pressure regulation over a 24-hour period. In patients with heart failure, it is used to improve symptoms and manage the long-term progression of the condition.

Monopril is unique among many ACE inhibitors because of its dual route of elimination from the body. It is processed and excreted by both the liver and the kidneys. This characteristic can be relevant for individuals with varying degrees of renal or hepatic function, as the body can compensate for one pathway by utilizing the other.

Regulatory References

  1. Fosinopril: MedlinePlus Drug Information

What side effects are possible with Monopril?

Possible side effects and safety information

The safety profile of Monopril (fosinopril sodium) is formally classified by regulatory authorities, detailing potential adverse reactions according to the physiological system affected and the frequency of occurrence.

Commonly Documented Adverse Reactions

Adverse effects listed as Very Common (ge 1/10) or Common (ge 1/100 to < 1/10) include reactions such as dizziness (very common), headache, a persistent, non-productive cough, and fatigue. Gastrointestinal effects, including nausea and vomiting, and cardiovascular effects like orthostatic hypotension (postural low blood pressure), are also frequently listed.

System-Organ Class (SOC) Example Adverse Reactions
Nervous System Dizziness, Headache
Respiratory System Cough, Dyspnea (shortness of breath)
Vascular Disorders Hypotension, Orthostatic Hypotension

Serious Adverse Reactions and Constraints

Official regulatory documentation highlights the potential for serious adverse reactions, notably Angioedema, which involves rapid swelling of the face, lips, tongue, or larynx, posing a risk of airway obstruction. Other serious documented effects include Acute Renal Failure (rare) and clinically significant elevations in serum potassium (Hyperkalemia).

Safety Considerations for Special Populations

ACE inhibitors, including Monopril, carry a stringent safety constraint regarding use during pregnancy. Use during the second and third trimesters is associated with potential fetal injury and death, requiring mandatory discontinuation when pregnancy is detected. Additionally, symptomatic hypotension is noted to be most likely at the start of treatment or following dose increases, particularly in patients with severe heart failure or salt/volume depletion.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory information for Monopril (fosinopril sodium) defines overdose primarily by the exaggerated extension of its therapeutic effect. The primary documented clinical manifestation is symptomatic hypotension (excessive reduction in blood pressure), which may lead to syncope (fainting). Laboratory findings may include hyperkalemia (elevated serum potassium levels).


When to Seek Urgent Help

The most critical and potentially life-threatening outcome documented in regulatory labeling is angioedema (swelling of the face, tongue, or throat). This requires immediate medical attention if there is any indication of laryngeal involvement or airway obstruction, as this condition can be fatal. The medication must be discontinued immediately if this swelling occurs.


Official Supportive Measures

No specific chemical antidote for fosinopril overdose is known or documented in official labeling. Management is symptomatic and supportive. For severe hypotension, official guidance describes placing the patient in a supine position and, if necessary, administering an intravenous infusion of 0.9% sodium chloride. For severe angioedema, administration of subcutaneous epinephrine solution 1:1000 is described as appropriate therapy. Patients must be carefully observed until all swelling disappears.

Therapeutic Uses of Monopril

Main Uses of Monopril

Monopril is a medication primarily prescribed for the management of cardiovascular conditions. It belongs to a class of drugs known as ACE (angiotensin-converting enzyme) inhibitors. Its main therapeutic applications include the treatment of high blood pressure and the management of heart failure.

Treatment of Hypertension

The primary use of Monopril is to treat hypertension, commonly known as high blood pressure. By inhibiting the ACE enzyme, the medication helps to relax and widen the blood vessels. This process reduces the resistance against which the heart must pump, leading to a decrease in systemic blood pressure levels. Long-term management of blood pressure is essential for reducing the risk of serious complications such as stroke and myocardial infarction.

Management of Heart Failure

Monopril is also utilized in the treatment of heart failure, a condition where the heart muscle is unable to pump blood as effectively as it should. In this context, the medication helps to decrease the workload on the heart. By lowering blood pressure and reducing fluid retention, it can help improve cardiac function and alleviate symptoms associated with the condition, such as shortness of breath and fatigue.

Benefits of Treatment

Therapy with Monopril offers several clinical benefits for patients with cardiovascular concerns. These benefits focus on long-term health maintenance and the stabilization of heart function.

  • Cardiovascular Protection: By maintaining blood pressure within a healthy range, the medication helps protect vital organs, including the kidneys and the brain, from the damage caused by chronic hypertension.
  • Improved Exercise Tolerance: In patients with heart failure, the reduction in cardiac strain can lead to an improved ability to engage in physical activity and daily routines.
  • Stabilization of Heart Function: Continuous use as prescribed can help prevent the worsening of heart failure symptoms and may reduce the frequency of hospitalizations related to heart health.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility for Monopril (Fosinopril Sodium)

Eligibility for Monopril is strictly defined by regulatory authorities based on contraindications, age, and concurrent health conditions. It is contraindicated for patients with a history of angioedema related to any ACE inhibitor, or patients with hereditary or idiopathic angioedema. Use is also prohibited in women in the second and third trimesters of pregnancy, and in patients taking aliskiren who have diabetes or renal impairment (GFR < 60 ml/min/1.73 m^2).

Population Restrictions

Category Eligibility Rule
Age Approved for adults and children mathbf6 to mathbf16 years old for hypertension. Use is not recommended in children under 6 years of age.
Pregnancy/Lactation Contraindicated in late pregnancy; use is not recommended during lactation.
Organ Function Caution is required for patients with severe renal impairment or hepatic impairment (liver dysfunction).
Comorbidities Caution is advised for patients with aortic or mitral valve stenosis or collagen vascular disease. The safety for treating heart failure in the pediatric population is not established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Monopril (fosinopril sodium) has documented interaction patterns that are classified based on official regulatory information concerning pharmacokinetic and pharmacodynamic effects.

Contraindicated Combinations and Mandatory Restrictions

Co-administration with Sacubitril/Valsartan is prohibited, requiring a mandatory 36-hour washout period when switching to or from Monopril due to the increased risk of angioedema. The combination with Aliskiren is contraindicated in patients who have diabetes mellitus or moderate-to-severe renal impairment.

Clinically Significant Interactions

Interacting Agent Official Interaction Outcome
Potassium-Sparing Diuretics/Supplements Increased risk of hyperkalemia (elevated serum potassium levels).
Lithium Reduced renal clearance of lithium, leading to increased serum concentrations and risk of toxicity.
NSAIDs (e.g., Ibuprofen) May reduce the antihypertensive effect and increase the risk of renal function deterioration, particularly in the elderly or volume-depleted.
Antacids (Aluminum/Magnesium) Reduced absorption of fosinoprilat, necessitating a 2-hour separation in administration time.

Co-administration with other antihypertensive agents may result in an additive hypotensive effect. Official documentation also notes that the risk of dizziness or fainting may be increased with alcohol consumption. The absorption of fosinopril is not clinically affected by food, although the rate of absorption may be reduced.

Mechanism of Action

Monopril (fosinopril) is an ester prodrug that undergoes rapid hydrolysis, primarily in the gastrointestinal mucosa and liver, to form its active metabolite, fosinoprilat.

Fosinoprilat acts as a competitive inhibitor of its biological target, the Angiotensin-Converting Enzyme (ACE), which is a key component of the Renin-Angiotensin-Aldosterone System (RAAS). ACE, a peptidyl dipeptidase, catalyzes the conversion of the inactive peptide angiotensin I to the potent vasoconstrictor, angiotensin II. By competitively binding to ACE's active site, fosinoprilat prevents this enzymatic conversion, resulting in decreased plasma concentrations of angiotensin II.

The reduction in angiotensin II levels leads to two primary downstream physiological cascades:

  1. Reduced Vasoconstriction: The diminished direct stimulation of Angiotensin II Type 1 (AT1) receptors on vascular smooth muscle results in arterial and venous vasodilation, decreasing peripheral vascular resistance.
  2. Decreased Aldosterone Secretion: Reduced angiotensin II-mediated stimulation of the adrenal cortex leads to a fall in aldosterone secretion. Lower aldosterone levels decrease the reabsorption of sodium and water in the renal collecting tubules, which can subsequently cause a small increase in serum potassium concentration.

Simultaneously, ACE is also responsible for degrading the vasodilator peptide, bradykinin (ACE is also known as kininase II). ACE inhibition by fosinoprilat attenuates bradykinin degradation, leading to increased local concentrations of bradykinin, which may contribute to systemic vasodilation. The net system-level physiological consequence of these actions is a reduction in systemic vascular resistance and a modulated fluid and electrolyte balance.

Dosage and Administration Information

How Monopril (Fosinopril Sodium) is Used — Administration Guidelines

Monopril is administered via the oral route as a tablet and is intended for long-term maintenance therapy. Its use is structured around specific starting doses, a multi-week titration logic, and defined intake conditions established for patient management.

Administration Scope

Feature Administration Guidelines
Route of administration The medication is administered via the oral route.
Dosing schedule Hypertension: Initial dose is 10 mg once daily. Maintenance is 20 mg to 40 mg daily, with a maximum of 80 mg once daily. Heart Failure: Initial dose is 10 mg once daily. The maximum dose is limited to 40 mg once daily.
Timing in relation to meals Can be taken with or without food, as absorption extent is not affected.
Age-group/Condition rules Renal Impairment (Heart Failure): Initial dose reduced to 5 mg once daily for patients with moderate to severe renal dysfunction. Pediatric (HTN): Approved for children 6 to 16 years; dosing is often weight-based.
Missed-dose rules If a dose is missed, take it as soon as possible. If it is almost time for the next dose, the missed dose should be skipped.
Special procedural conditions Should be taken at approximately the same time each day. Antacids containing aluminum or magnesium must be taken at least two hours apart from Monopril. Titration to the final maintenance dose occurs over a period of several weeks.

Summary of Use Protocol

The standard protocol involves a structured, once-daily oral administration that is subject to a careful multi-week titration based on the specific condition being managed. The protocol requires distinct maximum dose ceilings and starting dose adjustments, such as those related to a patient’s renal function, which define the drug's standardized usage pattern.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Monopril

This summary outlines the structure of the clinical research that has examined Monopril (fosinopril sodium), detailing the types of studies conducted and the outcomes that were measured, in strict compliance with official regulatory and scientific evidence standards.


Evidence for use in Managing Essential Hypertension

The research exploring Monopril in individuals with high blood pressure, a condition associated with physiological strain or stress, is characterized by randomized, double-blind, placebo-controlled trials (RCTs). These studies monitored measured Systolic and Diastolic Blood Pressure (BP). Research describes patterns related to blood pressure measurements during long-term follow-up periods extending up to two years.

However, evidence related to very long-term outcomes, beyond the periods blood pressure was monitored, is not fully characterized. Furthermore, long-term comparative evidence is lacking, and the results apply only to the populations studied within the trials.


Evidence for use in Symptomatic Chronic Heart Failure

Monopril was evaluated in patients with conditions marked by functional limitations, specifically mild-to-moderately severe chronic heart failure. The evidence is derived from large, controlled, multicenter clinical trials, often involving patients who were studied in conjunction with existing treatment protocols.

These studies explored outcomes related to physical discomfort and daily functioning or activity level. Researchers examined endpoints related to disease progression, tracking the frequency of major clinical events, such as hospitalization or patient withdrawal due to clinically worsening CHF symptoms. The primary clinical trials were not statistically powered to detect a difference in all-cause mortality. The primary functional assessments were also limited to short-term follow-up periods, meaning there is limited information for long-term outcomes regarding the functional status of these patients.


Evidence for Kidney and Vascular Health in High-Risk Patients

Research examined Monopril in cohorts with specific risk factors and conditions like Diabetic Nephropathy and general chronic kidney impairment. These investigations utilized randomized comparative trials.

The research examined markers of organ function, primarily focusing on changes in surrogate outcomes. This involved measured Proteinuria (protein excretion) and fluctuations in indicators like Estimated Glomerular Filtration Rate (eGFR). The evidence quality varies across studies, as some findings are derived from sub-group analyses, meaning the certainty remains low for certain long-term outcomes in all affected patient groups.

Frequently Asked Questions (FAQ)

Common questions about Monopril (FAQ)


Q: Is Monopril a water pill or a blood pressure medicine?

Monopril is a medicine used to treat high blood pressure and heart failure and belongs to a group called ACE inhibitors. While it works to adjust the body's fluid and salt balance, its main action is to relax and widen blood vessels. Official classification is as an ACE inhibitor, not primarily a diuretic, which is the type of medicine often referred to as a 'water pill'.


Q: How is Monopril different from other common blood pressure drugs like beta-blockers?

Monopril (fosinopril) is an ACE inhibitor, which means it works by acting directly on a system that regulates blood pressure by relaxing blood vessels. Beta-blockers belong to a different class of medicine that primarily works by slowing the heart rate. Both are used for cardiovascular regulation, but they achieve their effects through distinct mechanisms.


Q: How quickly can a person expect Monopril to start working?

Official product information indicates that an initial blood pressure lowering effect can be seen within about one hour after taking a dose. The maximum blood pressure reduction for that dose is typically reached within three to six hours. However, regulatory documents state that achieving the full long-term therapeutic benefit may require several weeks of consistent use.


Q: Is Monopril the same type of medicine as lisinopril or enalapril?

Monopril contains the active ingredient fosinopril. While lisinopril and enalapril are different chemical compounds, they all belong to the same pharmacological class: the ACE inhibitors. This means they share a similar mechanism of action for managing conditions like high blood pressure.


Q: Are there any specific foods or drinks that should be avoided when taking Monopril?

Regulatory documents suggest that alcohol should be used with caution, as it may increase the risk of side effects like dizziness. Official documentation specifies that antacids containing aluminum or magnesium must be taken at least two hours apart from Monopril, due to effects on absorption. There are no general restrictions on other common foods.


Q: Is it true that Monopril can affect kidney function?

Official information confirms that Monopril, like other ACE inhibitors, can cause changes in kidney function. Studies have also examined the use of Monopril in specific high-risk patients, such as those with diabetes, to assess effects on renal (kidney) disease progression.


Q: Can Monopril affect blood sugar levels?

Regulatory documents note caution regarding the use of Monopril combined with a medicine called aliskiren in patients with diabetes mellitus. However, official safety profiles do not widely specify a direct effect on blood sugar levels as a common adverse reaction of Monopril itself.


Q: Is Monopril safe for use in older adults?

Studies reviewed by regulatory bodies have not identified problems specific to the geriatric population that limit the drug's usefulness. However, age-related health conditions, such as heart or kidney problems, are factors that may lead to a dose adjustment according to official guidance.


Q: What happens if someone forgets to take a dose of Monopril?

Official guidance advises that if a dose is missed, it should be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely. Detailed instructions on managing missed doses are provided in the dedicated How to use Monopril section.


Q: How long does Monopril stay in the system after stopping it?

The active form of the medicine, called fosinoprilat, has an average effective half-life for accumulation of approximately 11.5 to 14 hours in most patients. This figure describes the time it takes for the amount of active medicine in the body to be reduced by half.


Q: Can a person become dependent on Monopril?

Official information indicates that Monopril is not addictive or habit-forming. It is intended for the long-term management of chronic conditions such as high blood pressure or heart failure, which require consistent therapy to maintain health effects.


Q: Is Monopril associated with dizziness or lightheadedness?

Yes. Dizziness is listed as a very common side effect in regulatory documents. Lightheadedness or faintness, especially when getting up suddenly from a sitting or lying position (orthostatic hypotension), is also a common side effect associated with this medicine.


Q: What happens to the body when Monopril is working?

The medicine works by preventing the body from making a potent hormone that normally causes blood vessels to tighten. The result is that the blood vessels relax and widen, which reduces the resistance to blood flow. This crucial physiological action helps to lower blood pressure and decrease the strain on the heart.


Q: Is Monopril a generic medicine or only available as a brand name?

Monopril is the brand name for the active drug fosinopril sodium. The active ingredient, fosinopril sodium, is also available in generic form for patient use.


Q: Can Monopril cause skin rash?

Yes, regulatory documents list rash as a possible dermatologic adverse reaction. It is also important to be aware of the potential for a rare but serious reaction called angioedema, which involves rapid swelling of the face, lips, or throat.


Q: Is it necessary to have blood tests done while taking Monopril?

Yes. Official information notes that blood tests are often required to check key health indicators, such as kidney function and potassium levels. This monitoring is typically performed when starting the medicine or following a dose adjustment to track the body's response.


Q: What should be known about using Monopril in people with a history of liver problems?

Since Monopril is a prodrug that is activated in the liver, official guidance notes that caution is required for patients with impaired liver function. In these cases, the body's ability to clear the active medicine may be decreased, which could lead to higher levels of the drug in the blood.


Q: What is the typical timeframe for seeing the full effect of Monopril?

While an initial effect is noted soon after the first dose, the achievement of the maximum therapeutic benefit for blood pressure may require a period of several weeks of therapy. This timeframe is necessary for the medicine to be titrated and for the body to fully adjust.


Q: Can people with a history of gout use Monopril?

Monopril is not strictly contraindicated for individuals with gout. However, official records from clinical trials have listed gout as an uncommon adverse event that was reported by a small percentage of patients.


Q: Are there any restrictions on driving or operating machinery while taking Monopril?

Official guidance states that patients must be aware that Monopril may cause dizziness or lightheadedness. Activities like driving or operating machinery may be restricted until they are aware of how they are affected by the medication.


Q: Is Monopril used to protect the kidneys in patients with diabetes?

Regulatory documents describe the use of Monopril in hypertensive patients with diabetic nephropathy to address the progression of renal disease. Studies have been conducted to examine this particular outcome.


Q: Why do regulatory documents emphasize the risk of use during the second and third trimesters of pregnancy?

Regulatory documents emphasize this due to the association between late-pregnancy use and the potential for fetal injury and death. The risks include problems with fetal kidney development, leading to conditions like reduced amniotic fluid (oligohydramnios).


Q: Is Monopril available in different strengths?

Yes. Monopril (fosinopril sodium) is available for oral administration in different strengths. These include 10 mg, 20 mg, and 40 mg tablets.


Q: Does Monopril commonly cause diarrhea or constipation?

Regulatory lists of common adverse reactions typically include gastrointestinal effects such as nausea and vomiting. Diarrhea has been reported in clinical trials, but constipation is generally not listed as a common side effect of this medicine.


Q: Can Monopril make someone more sensitive to the sun?

Official safety data indicates that photosensitivity (an increased sensitivity to the sun) is an uncommon adverse reaction that has been reported by a small number of patients in clinical trials.


Q: Is there a maximum dose of Monopril described in official regulatory information?

Yes. The official maximum dose is defined by the condition being treated. Regulatory information specifies a maximum of 80 mg once daily for hypertension and a maximum of 40 mg once daily for heart failure.


Q: Does Monopril affect electrolyte levels?

Yes. Because Monopril affects the body's salt and water balance, it can lead to changes in electrolyte levels. Specifically, official documents note that it can potentially cause hyperkalemia, which is an elevated level of potassium in the blood.


Q: What other medical conditions is Monopril sometimes used for besides its primary uses?

In addition to its main uses for high blood pressure and heart failure, official documents also note its use in hypertensive patients with diabetic nephropathy (kidney disease related to diabetes) to address the progression of renal damage, an area where studies have been conducted.

How should Monopril be stored and disposed of?

Monopril (fosinopril sodium) tablets must be stored at Controlled Room Temperature, specifically at 25 C (77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F). To maintain stability, the medication must be kept in its original container, which should be tightly closed to protect it from moisture and excess heat. Do not store this medicine in the bathroom.

Keep all medication out of the sight and reach of children and pets, and always lock safety caps.

The best disposal option for unused or expired Monopril is a local drug take-back program or mail-back envelope. As Monopril is not on the FDA's flush list, do not flush it down a toilet or pour it into a drain. If a take-back option is unavailable, discard the tablets in the household trash by mixing them with an undesirable substance (like coffee grounds or dirt) and sealing the mixture in a bag before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Monopril found in:

A-Z Index: